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2 
ABSTRACT 33 
Background: Anterior T wave inversion (ATWI) on an EKG in young white adults raises the 34 
possibility of cardiomyopathy, specifically arrhythmogenic right ventricular cardiomyopathy 35 
(ARVC). While the 2010 European consensus recommendations for EKG interpretation in young 36 
athletes state that ATWI beyond V1 warrants further investigation, the prevalence and 37 
significance of ATWI has never been reported in a large white asymptomatic population. 38 
Objective: This study investigated the prevalence and significance of ATWI in a large cohort of 39 
young, white adults including athletes. 40 
Methods: 14,646 individuals aged 16-35 years were evaluated with a health questionnaire, 41 
physical examination and 12-lead EKG, including 4,720 (32%) females and 2,958 (20%) 42 
athletes. ATWI was defined as T wave inversion in ≥2 contiguous anterior leads (V1-V4) and 43 
was investigated comprehensively to elucidate cardiac pathology.  44 
Results: ATWI was detected in 338 (2.3%) individuals and was more common in females than 45 
males (4.3% vs. 1.4%; p<0.0001), and among athletes compared with non-athletes (3.5% vs 46 
2.0%; p<0.0001). TWI was predominantly confined to leads V1-V2 (77%). Only 1.2% of 47 
females and 0.2% of males exhibited ATWI beyond V2. None of the individuals with ATWI 48 
fulfilled diagnostic criteria for ARVC after further evaluation. During a mean follow-up period 49 
of 23.1 (±12.2) months none of the individuals with ATWI experienced an adverse event. 50 
Conclusions: Anterior T wave inversion confined to V1-V2 is a normal variant or physiological 51 
phenomenon in asymptomatic white individuals without a relevant family history. Conversely, 52 
ATWI beyond V2 is rare, particularly in males, and may warrant investigation. These results will 53 
have a significant impact on EKG interpretation in young white adults. 54 
 55 
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Introduction 65 
There is general agreement that T wave inversion (TWI) in the inferior or lateral leads in 66 
young individuals warrants further investigation for cardiac disease, particularly cardiomyopathy 67 
(1). It is also well-established that adolescent athletes (2-6) and black adult athletes (7) 68 
frequently exhibit TWI in the anterior leads as part of the normal physiological or ethnic 69 
spectrum respectively. However, the general consensus on the significance of anterior T wave 70 
inversion (ATWI), defined as T wave inversion in ≥2 contiguous anterior leads (V1-V4) in white 71 
adults varies between expert recommendations for the interpretation of the athlete’s EKG. 72 
Whereas the European Society of Cardiology recommendations suggest further evaluation of 73 
athletes with TWI beyond V1 (8), more recent recommendations from the Seattle criteria 74 
advocate investigation only if TWI extends beyond V2 (9). 75 
Both consensus panels have relied on data from unselected (10) or small athlete cohorts 76 
(11); however recent studies reveal that TWI in leads V1-V2/V3 is detected in up to 6% of 77 
endurance athletes (12). Conversely, ATWI in V1-V2/V3 is a recognized repolarization 78 
abnormality in a significant proportion of patients with arrhythmogenic right ventricular 79 
cardiomyopathy (ARVC) and a small minority of patients with hypertrophic cardiomyopathy (7) 80 
which collectively account for > 40% of all sudden cardiac deaths (SCD) in young athletes (13). 81 
The differentiation of potentially pathological ATWI from a pattern that represents a normal 82 
variant or physiological remodelling in white adult athletes is essential to minimize the risk and 83 
consequences of an erroneous diagnosis (6,14). 84 
Since the prevalence of ATWI has been reported in black athletes and controls of both 85 
sexes, and in the adolescent population, this study focused on the prevalence and significance of 86 
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ATWI in a large cohort of apparently healthy white adults including a large proportion of 87 
athletes.  88 
Methods 89 
Setting 90 
The UK does not support a nationally sponsored screening programme for cardiac disease 91 
in young asymptomatic individuals in the absence of a family history of inherited cardiac disease 92 
or premature SCD. Several elite sporting organizations finance the evaluation of their athletes 93 
through the charitable organization, Cardiac Risk in the Young (CRY). These include premier 94 
league football clubs, the Lawn Tennis Association and the English Institute of Sport. Up to 95 
1000 athletes are tested annually at their specific clubs or national training camps, usually with 96 
history, examination and EKG. Financially endowed organisations such as the Football 97 
Association and the Lawn Tennis Association also incorporate echocardiography as standard. 98 
CRY also offers cardiac screening to all young (14- 35 years old) individuals who wish to 99 
be assessed even in the absence of symptoms, past history of cardiac disease or a family history 100 
of inherited cardiac diseases or SCD. Such screenings are conducted at community centres and 101 
high schools and are limited to history, examination and EKG with referral for further 102 
assessment only in those with abnormal preliminary investigations or if participating as controls 103 
for research studies. Screening events are advertised via the local media and on the CRY website 104 
(www.c-r-y.org.uk). Individuals from the general population, including those from local high 105 
schools, self-present to screening events whereas competitive athletes attend specified screening 106 
events mandated by their relevant sporting bodies. The CRY screening program is supervised by 107 
S.S. (principal investigator). 108 
Subjects 109 
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Between 2007 and 2013, 14,646 young, white adults aged between 16 and 35 years, 110 
underwent cardiac evaluation through CRY at various testing centres in England. Ethnicity was 111 
self-reported through the questionnaire that included terms such as white British, white Irish, 112 
white European and white other. 113 
Athletes 114 
The study included 2958 (20.2%) athletes competing at regional, national or international 115 
level who performed ≥8 hours of exercise per week. Sporting disciplines were categorized as 116 
predominantly endurance or strength. Endurance sports were defined as those typically resulting 117 
in >70% of maximal oxygen uptake (VO2 max) (15) and included badminton, basketball, 118 
canoeing, cycling, hockey, middle and long-distance running, rowing, rugby, soccer, squash, 119 
swimming, tennis and triathlon. All other sports were deemed strength disciplines, including 120 
cricket, diving, sailing, volley ball, water polo, weight-lifting and wrestling. 121 
Non- Athletes 122 
Non-athletes comprised of 11,688 (79.8%) individuals, whose primary inclusion criterion 123 
was a sedentary lifestyle (≤ 2 hours organized physical activity per week). Individuals with 124 
symptoms suggestive of cardiac disease, previous cardiac history or a family history of 125 
premature cardiac disease or SCD (<50 years) were excluded. 126 
Investigations 127 
Electrocardiogram 128 
A standard 12-lead EKG was performed in a supine position using a Marquette Hellige 129 
recorder (Milwaukee, USA) at a paper speed of 25 mm/s. P, Q, R, S, T wave voltages, ST 130 
segments, QRS, PR, and QT intervals were measured in each lead as described elsewhere (16). 131 
Leads V1-V4 were classified as anterior precordial leads. T wave deflection ≥ -0.1mV in these 132 
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leads was regarded as abnormal T wave inversion. Deep T wave inversion was defined as a T 133 
wave amplitude ≥ -0.2mV. In cases of biphasic T waves we applied the above definition to the 134 
negative component of the T wave. In cases with ATWI, the EKG was repeated ensuring that the 135 
leads were correctly positioned according to standard recommendations. In women the EKG 136 
electrodes were placed under the breast tissue as per American Heart Association 137 
recommendations (17). Partial right bundle branch block (pRBBB) was defined as QRS duration 138 
>0.1 but <0.12 seconds, with rSR’ morphology in lead V1 and qRS in V6 (18). Individuals with 139 
TWI and complete right bundle branch block (QRS ≥0.12 seconds) were excluded from the 140 
ATWI group.  Additional EKG markers compatible with ARVC were also sought, including 141 
terminal activation duration of the QRS complex ≥ 55msec in leads V1, V2 or V3, and the 142 
epsilon wave (19). 143 
The amplitude of the J-point (Jt) (20) was measured at the end of the QRS complex (the 144 
onset of the ST segment) with reference to the onset of the QRS complex. The Jt was considered 145 
elevated if Jt ≥0.1mV or depressed if Jt ≤ -0.1mV. The morphology of the ST segment in the 146 
anterior leads was ascertained in the M interval (the 100ms following Jt) (20). Accordingly, the 147 
ST segment at the onset of the M interval, i.e. Jt, was considered elevated if it were above Jt, 148 
depressed if it were below Jt and isoelectric if it were in line with Jt. Ascending ST segments 149 
were categorised as ascending convex or ascending concave (figure 1). 150 
Echocardiogram 151 
Two-dimensional (2D) transthoracic echocardiography was performed on all subjects 152 
with ATWI, with Philips (CPX50, iE33, Sonos 7500) and GE Vivid I (Tiral, Israel) machines. 153 
Standard views were obtained and dimensions of cavities and wall thickness measurements, 154 
pulsed colour and tissue Doppler measurements were made in accordance with established 155 
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guidelines (21-23) Right ventricular (RV) assessment was performed as outlined previously (14). 156 
RV regional wall-motion abnormalities (WMAs) were defined as akinetic, dyskinetic, or 157 
aneurysmal, in accordance with diagnostic criteria for ARVC (19).  158 
Echocardiography was also performed as standard on 1079 athletes and 769 non-athletes 159 
without ATWI of similar age and sex proportion who had normal physical examination and 160 
EKG. The echocardiogram was part of a mandatory pre-participation cardiac evaluation in 161 
athletes whereas the echocardiogram was conducted as part of research in volunteering non-162 
athletes. These cohorts served as comparative groups for athletes and non-athletes with ATWI 163 
respectively. 164 
All EKG and echocardiograms were performed by nationally-accredited cardiac 165 
physiologists. Echocardiography was conducted by physiologists blinded to the EKG findings. 166 
All EKG and echocardiogram images were reviewed by 2 independent cardiologists with the 167 
principal investigator (S.S.) adjudicating any queries. 168 
Further Investigations 169 
All subjects with ATWI underwent additional investigations to detect the broader 170 
phenotypic features of a primary cardiomyopathy, particularly ARVC, hypertrophic 171 
cardiomyopathy and dilated cardiomyopathy. Pre-determined diagnostic criteria for ARVC were 172 
based on the 2010 Modified Task Force criteria (19). Hypertrophic cardiomyopathy was 173 
considered in individuals with left ventricular hypertrophy where septal or wall thickness 174 
measured ≥15mm in any myocardial segment in the absence of another condition capable of 175 
producing left ventricular hypertrophy of the same magnitude (24,25). Dilated cardiomyopathy 176 
was considered in individuals with a dilated LV (males >59mm and females >53mm) when 177 
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accompanied by a reduced ejection fraction (< 52%) (29). The vast majority (1396; 95%) of 178 
further investigations were performed at our institution. 179 
Ambulatory EKG monitoring 180 
Ambulatory 24-hour EKG recording (Lifecard CF Holters, Spacelabs Healthcare, USA) 181 
was used to detect ventricular arrhythmias. Subjects were encouraged to continue day-to-day 182 
activities including exercise during monitoring. 183 
Exercise-testing 184 
Exercise testing was performed upright on a treadmill using the standard Bruce protocol 185 
(27). Subjects were exercised to volitional exhaustion and assessed for cardiac symptoms, 186 
ischaemic changes, attenuated blood pressure response or arrhythmias. 187 
Signal-averaged EKG 188 
Signal-averaged EKG was acquired according to accepted methodology using the same 189 
machines used for standard electrocardiography, with use of a 40Hz high-pass bi-directional 190 
filter (28). Late potentials were defined as abnormal values in one or more of the parameters in 191 
accordance the diagnostic criteria for ARVC (19). 192 
Cardiac Magnetic Resonance Imaging 193 
CMRI was performed using a Philips Achiever 3.0T TX scanner (Amsterdam, the 194 
Netherlands). Delayed gadolinium enhancement (DGE) images were acquired as previously 195 
described (29). Ventricular volumes and function were measured for both ventricles using 196 
standard techniques and analysed using semi-automated software (Extended MR workspace, 197 
Philips, Amsterdam, the Netherlands) (30). All measures were indexed to body surface area. 198 
Ethical approval 199 
9 
Ethics approval was granted by the National Research Ethics Service, Essex 2 Research 200 
Ethics Committee in the United Kingdom. Written consent was obtained from all subjects. 201 
Statistical analysis 202 
Data are expressed as mean (±SD) or percentages as appropriate and analyzed with SPSS 203 
software, version 20 (Chicago, IL). Comparison between groups was performed using Student t-204 
test for continuous variables with adjustment for unequal variance if needed and χ2 tests or Fisher 205 
Exact Tests for categorical variables. Univariate analyses were performed to determine variables 206 
(gender, age, athletic status, left ventricular end diastolic diameter and right ventricular outflow 207 
tract size (parasternal long and short axis measurements)) associated with ATWI. Multivariate 208 
logistic regression analyses were used to determine the independence of these associations. 209 
Significance was defined as p<0.05. 210 
Results 211 
Demographics 212 
The mean age of the cohort was 21.7 (±5.4) years.  Of the 14,646 subjects, 9,926 (67.8%) 213 
were male. 2063 (20.8%) males and 895 (19.0%) females were athletes. Athletes exercised for an 214 
average of 15.7 (±5.1) hours/ week compared with 1.8 (±0.6) hours/ week in non-athletes. 215 
Prevalence of Anterior T wave Inversion 216 
338 individuals (2.3%) exhibited ATWI. Individuals with ATWI were of similar age and 217 
had a similar mean body surface area compared to those without ATWI (Table 1). Anterior T 218 
wave inversion was more common in females compared with males (n= 203; 4.3% vs n= 135; 219 
1.4%: p<0.0001) and was more common in athletes than non-athletes (n= 103; 3.5% vs. n= 235; 220 
2%; p<0.0001) in both sexes (females: n= 58; 6.5% vs. n= 145; 3.8%; p= 0.0005, and males: n= 221 
45; 2.1% vs. n= 90; 1.1%; p= 0.0004) (Central Illustration). Among athletes, ATWI was more 222 
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prevalent in those engaging in endurance sports compared to strength sports (n= 82; 5.6% vs. 223 
n=41; 2.8%: p<0.0001). The prevalence of ATWI among those aged 16-21 years was not 224 
dissimilar to those aged above 21 years (2.28% vs 2.46%; p= 0.52). 225 
Distribution of Anterior T wave Inversion 226 
260 individuals (1.8%) revealed TWI confined to V1-V2. TWI confined to V1-V2 227 
constituted 77% of all ATWI. Only 78 (0.5%) individuals demonstrated TWI beyond V2 which 228 
was present in 56 (1.2%) females vs. 22 (0.2%) males (p<0.0001). Among athletes, TWI in V1-229 
V3 was detected in 19 (2.1%) females vs. 7 (0.3%) males (p<0.0001) (figure- central 230 
illustration). Four females, but none of the males, showed TWI extending to V4, which equated 231 
to just 2% of all ATWI in females. 232 
Deep ATWI was more common in males than females (55.6% vs. 33%; p=0.0166) but 233 
did not differ between athletes and non-athletes. 50 individuals with ATWI (14.8%) exhibited 234 
incomplete RBBB which never extended beyond V2. 235 
Jt elevation and ST segment morphology preceding ATWI 236 
Among individuals with ATWI, Jt elevation was more common in athletes than non-237 
athletes (49% vs. 29%; p=0.0008) and more common in males than females irrespective of 238 
athletic status (athletes: 71.1% vs. 31.0%, p= 0.0004; non-athletes: 58.9% vs. 10.3%, p< 0.0001). 239 
None of the individuals with ATWI demonstrated a depressed Jt. 240 
Males frequently showed an elevated ST-segment that of ascending convex morphology 241 
(42%), followed by an ascending concave morphology (33%) and an isoelectric pattern (25%).  242 
In females with ATWI the ST segment was most commonly isoelectric (57%), followed by 243 
ascending convex (24%) and ascending concave (19%) morphologies. Only one individual with 244 
ATWI demonstrated a depressed ST segment (Figure 2). 245 
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Cardiac Structure and Function in Individuals with ATWI 246 
The echocardiographic results of all 338 individuals with ATWI (athletes= 103, non-247 
athletes= 235) were compared with the results of 1848 individuals without ATWI (athletes= 248 
1079, non-athletes= 769). Athletes revealed larger ventricular dimensions compared to non-249 
athletes irrespective of ATWI. There were no differences in left or right ventricular dimensions 250 
or function in individuals (athletes and non-athletes) with ATWI compared to those without 251 
AWTI (Table 2). 252 
CMRI was performed on 250 (74%) subjects with ATWI. Athletes demonstrated larger 253 
left and right ventricular volumes and masses compared to non-athletes (Table 2). Following 254 
gadolinium there was no evidence of late enhancement in any subject. None of the individuals 255 
with ATWI showed unequivocal diagnostic features of ARVC, hypertrophic cardiomyopathy or 256 
dilated cardiomyopathy. 257 
Other Investigations 258 
Signal-averaged Electrocardiogram 259 
316 (93%) individuals with ATWI underwent SAEKG and 21 (7%) showed an 260 
abnormality in one of the three parameters. The most common abnormality was filtered QRS 261 
prolongation (60%), a phenomenon that has been reported previously in healthy individuals 262 
(31,32). 263 
Exercise Stress Testing and Ambulatory EKG Monitoring 264 
274 (81%) individuals with ATWI underwent an exercise stress test and 293 (87%) had 265 
24 hour EKG monitoring. None of the individuals with ATWI exhibited an arrhythmia during 266 
exercise, other than occasional isolated ventricular ectopics (n= 10; 3%) of right or left 267 
12 
ventricular origin in the early stages of exercise. Similarly, none showed >500 ventricular 268 
ectopics or runs of non-sustained ventricular tachycardia during Holter monitoring (19). 269 
Determinants of Anterior T wave Inversion 270 
Univariate predictors of ATWI were female gender and athletic status. Stepwise logistic 271 
regression identified female gender (OR 3.1, 95% CI 1.96-4.90, p<0.001) and athletic status (OR 272 
3.3, 95% CI 1.91-5.63, p=0.001) as being independently associated with ATWI in the screened 273 
adult population, irrespective of age. 274 
Detection of Cardiac Pathology 275 
Following comprehensive clinical evaluation of 274 (81%) individuals with ATWI 276 
(including echocardiography in all 338 individuals) and a mean follow-up period of 23.1 ±12.2) 277 
months, we could not diagnose ARVC or any other cardiomyopathy. However, 16 athletes and 278 
10 non-athletes with ATWI fell into the gray zone, in which structural changes attributed to 279 
physiological adaptation needed to be differentiated from primary cardiomyopathies. These 280 
included: 2 athletes and 3 non-athletes with an indexed RVOTplax ≥ 19 mm/m2; 1 athlete with a 281 
maximal left ventricular wall thickness of 13mm; and 6 non-athletes who initially demonstrated 282 
an absolute LVEDD above the upper limit of normal (non-athletes: LVEDD; males >59mm and 283 
females >53mm26 and athletes with an LVEDD > 60mm33). 284 
Identification of Minor Cardiac Pathology 285 
Echocardiography in all 338 subjects with ATWI failed to show akinetic segments or 286 
regional wall motion abnormalities affecting the right ventricle. A small proportion revealed 287 
minor pathology in 5 (1.5%) including: bicuspid aortic valve (n= 2; 0.6%), mitral valve prolapse 288 
with moderate mitral regurgitation (n= 1; 0.3%); atrial septal defect (n=1; 0.3%) and patent 289 
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ductus arteriosus (n= 1; 0.3%). 7 (2%) individuals had a patent foramen ovale noted and pectus 290 
excavatum was noted in 2 (0.6%) cases. 291 
Discussion 292 
The detection of lateral or infero-lateral T wave inversion in young black or white 293 
individuals has a relatively high yield for the diagnosis of cardiomyopathy (1). Whereas ATWI is 294 
a benign variant in healthy adolescents of all ethnic origins and in black adolescent and adult 295 
athletes, its significance in asymptomatic white adults is unknown. However, between 50-60% of 296 
probands with ARVC show ATWI in leads V1-V3 (34). This study of almost 15,000 healthy, 297 
white adults, including 4,720 females and almost 3,000 athletes, showed that ATWI beyond V1 298 
was present in a small proportion of individuals (2.3%) and this prevalence fell to just 0.5% 299 
beyond V2. ATWI was more common in females than males irrespective of athletic status and 300 
validates data from much smaller studies from 6- 7 decades ago (35,36). Several postulations for 301 
this gender difference have been proposed including varying levels of sympathetic innervation 302 
and anatomical differences in chest wall structure, specifically breast tissue. Based on the fact 303 
that the prevalence of anterior T wave inversion is almost identical in prepubertal males and 304 
females (3) we suspect that sex differences in adults are likely to reflect differences in lead 305 
placement as a result of increased breast tissue in females. 306 
Prevalence of Anterior T wave Inversion in Athletes 307 
Athletes demonstrated a greater prevalence of ATWI than non-athletes, particularly those 308 
engaging in >15 hours/ week of exercise. Such intense exercise regimes, particularly in 309 
endurance sports, place a greater haemodynamic load on the right ventricle that may manifest on 310 
the EKG as ATWI. Our study however, was unable to demonstrate any structural differences in 311 
the right ventricle between individuals with ATWI and those without. 312 
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Significance of Extrapolating Data from Probands with Cardiomyopathy to low-risk Populations 313 
There are justifiable concerns about the association of ATWI with an underlying 314 
cardiomyopathy such as ARVC or hypertrophic cardiomyopathy. While isolated ATWI is rare in 315 
hypertrophic cardiomyopathy is a rare finding (2), ATWI beyond V2 in probands with ARVC is 316 
common and classified as a major repolarization abnormality in the Revised Task Force Criteria 317 
for ARVC (19). In this study, none of the athletes with ATWI in V2/V3 fulfilled diagnostic 318 
criteria for ARVC based on a combination of health questionnaire, EKG, and echocardiography 319 
in 100% of cases, SAEKG in 93%, 24 hour EKG in 87%, exercise testing in 81% and CMRI in 320 
74% . This observation highlights that data derived from probands with ARVC for generating 321 
diagnostic criteria lack specificity in low risk populations (29). However, TWI beyond V2 was 322 
present in just 1 in 200 white adult athletes and could justify detailed assessment to exclude 323 
ARVC or any other cardiomyopathy. Our data supports the consensus based Seattle 324 
recommendations, which pragmatically suggest that only TWI beyond V2 in asymptomatic white 325 
athletes requires further evaluation (9). However, these recommendations are at odds with the 326 
European Society of Cardiology recommendations and the recently published refined criteria 327 
(8,37). Given the potentially sinister ramifications of false negative tests with regard to ARVC in 328 
particular more robust data is necessary before such criteria can be adopted with more certainly 329 
in future updates for EKG interpretation in athletes.  This comprehensive study of a large 330 
population of athletes with ATWI provides support for the Seattle consensus. 331 
Potential Markers of Disease in Individuals with Anterior T wave Inversion 332 
In athletes with TWI beyond V1, information from the preceding Jt or ST segment may 333 
provide valuable diagnostic information when considering ARVC. Based on comparisons 334 
between 45 athletes with ATWI and 35 patients with ARVC we have previously reported that a 335 
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Jt and ST segment in line with the onset of the QRS complex  or a depressed ST segment 336 
preceding ATWI is a powerful discriminator between the two entities (29). Moreover, a recent 337 
study examining ATWI as a marker of cardiomyopathy in a small cohort of athletes of black and 338 
white ethnicity, showed that Jt elevation (≥ 0.1mV) preceding the TWI excluded ARVC.34 Our 339 
large study of almost 15,000 white individuals provides validation for these concepts in males 340 
but reveals that Jt may be in line with the onset of the QRS complex  in as many as 50% of 341 
healthy females with ATWI. Importantly, only 1 athlete demonstrated ATWI with preceding ST 342 
segment depression and none of the individuals with ATWI showed Jt depression suggesting that 343 
the presence of such electrical markers may be pointers for cardiac pathology. 344 
There remains the possibility that ATWI confined to V1-V2 may be a manifestation of 345 
ARVC. We have examined our own cohort of 35 probands with ARVC and identified ATWI in 346 
V1-V2 alone in 6%. All of these patients either expressed symptoms or other electrical features 347 
diagnostic of ARVC (29). 348 
Limitations 349 
This study was cross-sectional in nature and although there were no adverse clinical 350 
events in the ATWI group during a follow-up of nearly 2 years, the authors cannot be certain 351 
whether ATWI may precede the development of ARVC by several years. Familial evaluation 352 
was not performed in any of the individuals with ATWI because none fulfilled overt criteria for a 353 
cardiomyopathy. However, the authors concede that such practice may have highlighted some 354 
individuals with incomplete expression of disease.  A small proportion of ATWI individuals 355 
were lost to follow up due to logistical difficulties that could not be overcome (e.g. emigration). 356 
Cardiac MRI is the recognized gold standard for the investigation of primary cardiomyopathies 357 
but was only performed in 250 (74%) individuals with ATWI. However, 81% of all individuals 358 
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with ATWI had all of EKG, echocardiography, SAEKG, Holter and exercise stress test which 359 
are sufficient to diagnose ARVC according to modified task force criteria (19). Voluntary 360 
cardiac screening programmes of non-athletes in the community conducted through 361 
organizations such as CRY do have a potential for inherent selection bias though given the large 362 
numbers included in this study of nearly 15,000 participants, the potential of any such bias is 363 
significantly mitigated. 364 
Conclusions 365 
ATWI is present in 2.3% of the young white population and is more common in females 366 
and in athletes. Almost 80% is confined to V1-V2 and has a poor diagnostic yield for cardiac 367 
pathology, implying that this electrocardiographic pattern could be considered a normal 368 
phenomenon in asymptomatic individuals without a family history of cardiomyopathy or 369 
premature SCD. In contrast, TWI extending beyond V2 is present in only 1% females and 0.2% 370 
males and may justify further evaluation in white individuals, particularly when preceded by Jt 371 
depression or ST segment depression. 372 
  373 
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Clinical Perspectives 374 
Competency in Medical Knowledge: Anterior T wave inversion confined to V1-V2 may be a 375 
normal variant or physiological phenomenon in asymptomatic white individuals without a 376 
relevant family history.  377 
Translational Outlook: The results of this study will have a significant impact on EKG 378 
interpretation in young white athletes and non-athletes as the rarity of T wave inversion beyond 379 
V2 (1 in 200) may justify further investigation. 380 
  381 
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Figure Legends 481 
Central illustration: Prevalence of anterior T wave inversion (ATWI) in the adult white 482 
population aged 16-35 years old. The overall prevalence of ATWI in adult white individuals 483 
was 2.3%. ATWI was more common in females and in athletes. The prevalence of ATWI 484 
beyond V2 was rare, falling to 0.2% in male non-athletes. 485 
Figure 1: ST segment morphology.(A) The vertical solid line and the vertical dashed line 486 
define the M interval, which has a duration of 100ms. The horizontal dashed line through the 487 
onset of the QRS complex provides the reference point for the measurement of Jt. Jt is elevated 488 
at 0.2mV with a convex appearance.  ST segment morphologies with anterior T wave inversion 489 
in chest leads V2 and V3 are shown as: B) ascending convex; C) isoelectric; D) ascending 490 
concave; E) depressed. 491 
Figure 2: Bar graph demonstrating the type of ST segment morphology preceding anterior 492 
T wave inversion (ATWI) in healthy individuals and ATWI according to sex. An ascending 493 
convex and ascending concave ST segment morphology was more common in males than 494 
females.  Females more commonly demonstrated an isoelectric ST segment. 495 
  496 
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Table 1: Demographics and EKG characteristics of individuals with and without anterior 497 
T wave inversion 498 
 
Characteristic 
Anterior 
TWI 
population 
(n =338) 
Population 
without 
anterior TWI 
(n=14,308) 
p value 
Demographics 
 
 
Age (years) 21.1 ± 5.4 21.7 ± 5.3 0.0398 
Sex (% female) 60.1 31.6 <0.0001 
Athletes (%) 30.5 20.0   0.0003 
BSA (m2) 1.81 ± 0.3 1.91 ± 0.2 <0.0001 
Blood pressure (mmHg) 121/66 ±12/7 123/80 ±10/6 0.0003 
EKG parameters 
 
 
 
 
  
     
      
Heart rate (bpm) 64 ± 14 66 ± 14 <0.0001 
PR (ms) 150 ± 25 151 ± 32 <0.0001 
QRS (ms) 93 ± 12 92 ± 13 <0.0001 
QTc (ms) 421 ± 28 412 ± 20 <0.0001 
Incomplete RBBB (%) 17.7 5.5 <0.0001 
LBBB (%) 0 0.02 0.77 
LVH (%) 17.9 10.1 <0.0001 
RVH (%) 1.2 1.1 0.93 
ER (%) 15.1 9.7 0.0018 
Pathol Q waves (%) 0.5 0.3 <0.0001 
LA enlargement (%) 3.3 1.4 0.002 
RA enlargement (%) 1.4 0.6 0.1 
25 
LAD (%) 1.0 1.2 0.83 
RAD (%) 0.7 0.4 0.49 
Pre-excitation (%) 0.5 0.5 0.93 
 499 
 500 
Values are mean ± SD or % overall population 501 
BSA= body surface area; EKG = 12 lead electrocardiogram; ER = early repolarisation; LA = left 502 
atrial; LAD = left axis deviation; LBBB= left bundle branch block; LVH= left ventricular 503 
hypertrophy; RA = right atrial; RAD = right axis deviation; RVH = right ventricular hypertrophy; 504 
TWI = T wave inversion.  505 
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Table 2: Echocardiographic and Cardiac Magnetic Resonance Measurements of Athletes and Non-athletes with and without Anterior T 
wave Inversion. 
Measurement 
Athletes (n= 1182) Non-athletes (n= 1,004) 
With Ant TWI 
( n= 103) 
Without Ant 
TWI (n= 1079) 
 
p value 
With Ant TWI 
(n=235) 
Without Ant 
TWI (n= 769) 
 
p value 
Ao (mm) 28.0 ± 4.3 28.6 ± 4.5 0.2306 27.1 ± 3.6 27.4 ± 3.8 0.2839 
LA (mm) 33.1 ± 6.1 33.5 ± 4.9 0.4394 31 ± 4.3 31.3 ± 5.5 0.443 
LVEDd (mm) 50.8 ± 5.8 51.5 ± 5.6 0.2272 48.1 ± 4.5 48.5 ± 5.8 0.3315 
LVESd (mm) 34.0 ± 6.1 33.9 ± 4.8 0.844 31.1 ± 3.9 31.6 ± 5.1 0.1666 
MLVWT (mm) 9.2 ± 2.3 8.9 ± 2.1 0.1699 8.5 ± 2.2 8.3 ± 1.5 0.1126 
LVMI (g/m2) 105 ± 15 103 ± 16 0.2233 94 ± 8 95 ± 9 0.1267 
EF (%) 60 ± 9 59 ± 8 0.231 66 ± 8 67 ± 9 0.1267 
RVOTplax (mm) 29.9 ± 5.4 29.8 ± 4.8 0.8417 26.0 ± 3.7 25.4 ± 3.6 0.1072 
RVOTplax in(mm/m2) 16.7 ± 2.1 16.8 ± 3.7 0.7871 15.2 ± 2.5 14.8 ± 3.1 0.2041 
RVOTpsax (mm) 31.6 ± 4.9 32.3 ± 5.6 0.221 28.2 ± 5.8 29.1 ± 5.7 0.1266 
RVOTpsaxin(mm/m2) 17.8 ± 2.5 17.5  ± 2.9 0.3106 16.0 ± 2.1 16.1 ± 2.5 0.6945 
RVOT2 (mm) 25.8 ± 4.8 25.1 ± 4.4 0.1263 22.6 ± 3.7 23.2 ± 4.3 0.0537 
27 
RVD1 (mm) 41.1 ± 6.6 40.6 ± 5.8 0.4093 35.3 ± 4.9 35.6 ± 5.5 0.4534 
RVD2 (mm) 34.1 ± 6.4 33.3 ± 5.5 0.165 28.2± 4.5 28.7 ± 5.7 0.2181 
RVD3 (mm) 84.2 ± 10.5 82.0 ± 13.2 0.1008 73.5 ± 11.4 74.9 ± 11.1 0.093 
RVWT (mm) 4.8 ± 1.5 4.6 ± 1.3 0.1416 4.2 ± 0.8 4.1 ± 1.0 0.1613 
TAPSE (mm) 23.4 ± 5.3 23.5 ± 4.2 0.8219 22.8 ± 4.7 22.9 ± 4.5 0.768 
PASP (mmHg) 17.6± 7.7 15.9 ± 6.5 0.0128 17.8 ± 3.3 18.3 ± 4.0 0.0816 
TV E/A 1.9 ± 0.5 2.0 ± 0.4 0.0181 1.9 ± 0.6 2.0 ± 0.8 0.0771 
TV S’ (cm/s) 14.8± 2.6 14.9 ± 2.5 0.6992 14.6 ± 2.8 14.2 ± 2.8 0.0556 
TV E’ (cm/s) 13.9 ± 3.4 14.1 ± 3.1 0.5353 14.9 ± 2.9 15.1 ± 3.5 0.426 
RAA (cm2) 19.2 ± 3.4 18.8 ± 3.7 0.2915 15.2 ± 2.8 15.1 ± 4.8 0.7613 
RV FAC (%) 38.7 ± 4.9 39.6 ± 4.8 0.0698 36.2 ± 4.1 37.3 ± 6.2 0.0108 
CMR 
ATWI Athletes 
(n=76) 
  ATWI Non- athletes (n= 
174) 
  
LVM- i (g/m2) 105 ± 15   94 ± 9 p<0.05  
LVEDV- i (ml/m2) 105.8 ± 15   94.3 ± 14 p<0.05  
RV EF (%) 52.5 ± 5.1   55.5 ± 5.9 p<0.05  
RVEDV- i(ml/m2) 105.3 ± 14   94.3 ± 14 p<0.05  
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Values are mean ±SD. Ao= aorta; CMR= cardiac magnetic resonance imaging; EF= ejection fraction by Simpson’s biplane; LA= left 
atrial; LVEDd= left ventricular end diastolic diameter; LVEDV= left ventricular end diastolic volume; LVESd= left ventricular end 
systolic diameter; LVM i = left ventricular mass index (g/m2); MLVWT= maximum left ventricular wall thickness; PASP= pulmonary 
artery systolic pressure; RAA= right atrial area; RVD1= right ventricular basal dimension; RVD2= right ventricular midventricular 
dimension; RVD3= right ventricular longitudinal dimension; RVEDV= right ventricular end diastolic volume; RV `EF= right 
ventricular ejection fraction; RVOT1= proximal right ventricular outflow tract dimension; RVOT2= distal right ventricular outflow 
tract dimension; RVOTplax= right ventricular outflow tract dimension (parasternal); ; RVOTsax= right ventricular outflow tract 
dimension (short axis); RVWT= right ventricular free wall thickness; S’= peak systolic velocity; TAPSE= tricuspid annular plane 
systolic excursion; TV= tricuspid valve. 
LGE (%) 0   0 -  
